Full Text
The Full Text of this article is available as a PDF (541.5 KB).
References
- 1. Sianos G, Papafaklis MI, Daemen J, Vaina S, van Mieghem CA, et al.: Angiographic stent thrombosis after routine use of drug‐eluting stents in ST‐segment elevation myocardial infarction: The importance of thrombus burden. J Am Coll Cardiol 2007; 50: 573–583. [DOI] [PubMed] [Google Scholar]
- 2. ASSENT‐4 PCI Investigators . Primary versus tenecteplase‐facilitated percutaneous coronary intervention in patients with ST‐segment elevation acute myocardial infarction (ASSENT‐4 PCI): randomised trial. Assessment of the safety and efficacy of a new treatment strategy with percutaneous coronary intervention. Lancet 2006; 367: 569–578. [DOI] [PubMed] [Google Scholar]
- 3. Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events trial (FINESSE) ‐ Presented by Dr. Steve Ellis at the European Society of Cardiology Congress, September 2007; Vienna, Austria.
- 4. Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS AMI): Presented by Dr. Carlo Di Mario at the European Society of Cardiology Congress, September 2007; Vienna, Austria.
- 5. Silva‐Orrego P, Colombo P, Bigi R, Gregori D, Delgado A, et al. Thrombus aspiration befote primary angioplasty improves myocardial reperfusion in acute myocardial infarction. The DEAR‐MI (Dethrombosis to Enhance Acute Reperfusion in Myocardial Infarction) Study. J Am Coll Cardiol 2006; 48: 1552–1559. [DOI] [PubMed] [Google Scholar]